Characterization of Mimotopes Mimicking an Immunodominant Conformational Epitope on the Hepatitis C Virus NS3 Helicase

Journal of Medical Virology

Volumn 72, Issue 3, 2004, Pages 385-395

  Jolivet Reynaud, Colette ^a   Adida, Anne ^a   Michel, Sandrine ^a   Deléage, Gilbert ^b   Paranhos Baccala, Glaucia ^a   Gonin, Virginie ^a   Battail Poirot, Nicole ^c   Lacoux, Xavier ^c   Rolland, Dominique ^c  

^a BIOMÉRIEUX   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c bioMérieux ^*  (France)

Author keywords

HCV human response; Mimotopes; Monoclonal antibody; NS3 helicase; Phage displayed peptide library

Indexed keywords

EPITOPE; HELICASE; MIMOTOPE; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 3; PEPTIDE LIBRARY; PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SEROCONVERSION; SERUM; VIRUS IDENTIFICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE LIBRARY; RNA HELICASES; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 1642457386     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20002     Document Type: Article

References (45)

1. Arnold FH. 1991. Metal-affinity separations: A new dimension in protein processing. Bio/Technol 9:151-156.
2. Bartenschlager R, Ahlborn LL, Mous J, Jacobsen H. 1993. Non structural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 67:3835-3844.
3. Bartoli F, Nuzzo M, Urbanelli L, Bellintani F, Pressi C, Cortese R, Monaci P. 1998. DNA-based selection and screening of peptide ligands. Nat Biotechnol 16:1068-1073.
4. Chaudhary RK, Jacobsen H. 1994. Performance of third-generation confirmatory tests for detection of antibody to hepatitis virus. J Clin Microbiol 32:2606-2608.
5. Chen M, Sällberg M, Sonnerborg A, Jin L, Birkett A, Peterson D, Weiland O, Milich DR. 1998. Human and murine antibody recognition is focused on the ATPase/helicase domain, but not the protease domain of the hepatitis C virus non-structural 3 protein. Hepatology 28:219-224.
6. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley LR, Houghton M. 1989. Isolation of a cDNA clone from a blood-borne non-A, non-B viral hepatitis C virus. Science 244:359-362.
7. Claeys H, Volckaerts A, Mertens W, Liang Z, Fiten P, Opdenakker G. 1995. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus. J Med Virol 45:273-281.
8. Cortese R, Felici F, Galfre G, Luzzago A, Monaci P, Nicosia A. 1994. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol 12:262-267.
9. Cortese I, Tafi R, Grimaldi LME, Martino G, Nicosia A, Cortese R. 1996. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci USA 93:11063-11067.
10. Deroo S, Muller CP. 2001. Antigenic and immunogenic phage displayed mimotopes as substitute antigens: Applications and limitations. Comb Chem High Throughput Screen 4:75-110.
11. Folgori A, Tafi R, Meola A, Felici F, Galfré G, Cortese R, Monaci P, Nicosia A. 1994. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 13:2236-2243.
12. Frank R, Döring R. 1988. Simultaneous multiple synthesis under continuous flow conditions on cellulose paper discs as segmental solid synthesis. Tetrahedron 44:6031-6040.
13. Gretch DR, Suter M, Stinski MF. 1987. The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpes hydrophobic proteins or glycoproteins. Anal Biochem 163:270-277.
14. Houghton M, Weiner A, Han J, Kuo G, Choo QL. 1991. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
15. Jin L, Peterson DL. 1995. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys 323:47-53.
16. Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, Bridon L, Trabaud MA, Battail N, Sibal G, Jolivet M. 1998. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection. J Med Virol 56: 300-309.
17. Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B. 1999. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin Immunol 93: 283-299.
18. Jolivet-Reynaud C, Lesenéchal M, O'Donnell B, Becquart L, Foussadier A, Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M. 2001. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol 65: 241-249.
19. Kwong AD, Kim JL, Lin C. 2000. Structure and function of hepatitis C virus NS3 helicase. Curr Top Microbiol Immunol 242:171-196.
20. Köhler G, Milstein C. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256:45-47.
21. Köhler G, Milstein C. 1976. Derivation of specific antibody producing tissue, culture and tumor lines by cells fusion. Eur J Immunol 6: 511-519.
22. Li JS, Vitvitski L, Tong SP, Trepo C. 1992. PCR detection of HCV RNA among french non-A, non-B hepatitis patients. Arch Virol 4(suppl):234-237.
23. Lu YA, Clavijo P, Galantino M, Shen ZY, Liu W, Tam JP. 1991. Chemically unambiguous peptide immunogen: Preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system. Mol Immunol 28:623-630.
24. Ludmerer SW, Benincasa D, Mark GE III. 1996. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J Virol 70: 4791-4794.
25. Michel S, Deléage G, Charrier JP, Passagot J, Battail-Poirot N, Sibal G, Jolivet M, Jolivet-Reynaud C. 1999. Anti-free Prostate specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling. Clin Chem 45:638-650.
26. Minenkova O, Gargano N, De Tomassi A, Bellintani F, Pucci A, Fortugno P, Fuscaldi E, Pessi A, Rapicetta M, Micelli M, Iudicone P, Cortese R, Felici F, Monaci P. 2001. ADAM-HCV, a new concept diagnostic assay for antibodies to hepatitis C virus in serum. Eur J Biochem 268:4758-4768.
27. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, La Monica N, Habets W. 1994. Significance of the immune response to a major conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J virol 68:4829-4836.
28. Neddermann P, Tomei L, Steinkühler C, Gallinari P, Tramontano A, De Franscesco R. 1997. The non structural proteins of the hepatitis C virus: Structures and functions. Biol Chem 378: 469-476.
29. Ou-Yang P, Chiang L, Chen Y, Yang P, Chi W, Chen P, Chen D. 1999. Characterization of monoclonal antibodies against hepatitis C virus non structural Protein 3: Different antigenic determinants from human B cells. J Med Virol 57:345-350.
30. Pereboeva L, Pereboev A, Morris G. 1998. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries. J Med Virol 56:105-111.
31. Pereboeva L, Pereboev A, Wang L, Morris G. 2000. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen. J Med Virol 60:144-151.
32. Prezzi C, Nuzzo M, Meola A, Delmastro P, Galfre G, Cortese R, Nicosia A, Monaci P. 1996. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J Immunol 156:4504-4513.
33. Sambrook J, Fritsch EF, Maniatis T, editors. 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
34. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
35. Scott JK, Smith GP. 1990. Searching for peptide ligands with an epitope library. Science 249:386-390.
36. Smith DB, Johnson KS. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
37. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A, Rice CM, Feinstone SM, Collett MS. 1993. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with related pestivirus and flavirus enzymes. J Virol 67:6152-6158.
38. Sällberg M, Zhang ZX, Chen M, Jin L, Birkett A, Peterson DL, Milich DR. 1996. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein. J Gen Virol 77:2721-2728.
39. Tam JP. 1988. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 85:5409-5413.
40. Urbanelli L, Fortugno P, Bartoli F, Nuzzo M, De Tomassi A, Felici F, Monaci P. 2000. Affinity maturation of ligands for HCV-specific serum antibodies. J Immunol Methods 236:167-176.
41. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, di Nello R, van Boven JJP, Winkel I, Mulder-Forkerts D, van Exel-Oehlers PJ, Schausberg W, Lentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. 1991. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317-319.
42. Yao N, Hesson T, Cable M, Hong Z, Kwong AD, Le HV, Weber PC. 1997. Structure of the hepatitis C virus RNA helicase domain. Nature Struct Biol 4:463-467.
43. Yayon A, Aviezer D, Safran M, Gross JL, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E. 1993. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a randomphageepitope library. Proc Natl Acad Sci USA 90:10643-10647.
44. Zhang ZX, Lazdina U, Chen M, Peterson D, Sällberg M. 2000, Characterization of a monoclonal antibody and its single-chain antibody fragment recognizing the nucleoside triphosphate/helicase domain of the hepatitis C virus nonstructural 3 protein. Clin Diagn Lab Immunol 7:58-68.
45. Zhu Z, Minenkova O, Bellintani F, De Tomassi A, Urbanelli L, Felici F, Monaci P. 2000. 'In vitro evolution' of ligands for HCV-specific serum antibodies. Biol Chem 381:245-254.